Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹24Cr
Food - Processing - Others
Rev Gr TTM
Revenue Growth TTM
10.87%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

TAPIFRUIT
VS
| Quarter | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | 71.2 | 19.0 | 34.1 | -11.0 | -15.3 | -3.1 | 26.1 |
| 5 | 9 | 9 | 12 | 11 | 11 | 10 | 11 | 12 |
Operating Profit Operating ProfitCr |
| -0.4 | 11.7 | -0.1 | 4.3 | 2.3 | 0.4 | -3.3 | -2.2 | 4.7 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | | | -2.3 | -56.7 | 100.0 | -173.1 | | -252.6 | -30.3 |
| -8.7 | 5.9 | -5.2 | 2.2 | 0.0 | -1.8 | -7.8 | -6.5 | -8.0 |
| 0.0 | 0.0 | -1.1 | 0.7 | 0.0 | -0.4 | -1.8 | -1.6 | -2.3 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 36.3 | 7.8 | -9.4 | 12.7 |
| 14 | 20 | 22 | 21 | 22 |
Operating Profit Operating ProfitCr |
| 7.7 | 2.5 | 1.4 | -2.7 | 1.5 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 2 |
| 0 | 0 | 0 | -1 | 0 |
| 0 | 0 | 0 | 0 | 0 |
|
| | -221.2 | 3.5 | -684.5 | -16.0 |
| 1.0 | -0.9 | -0.8 | -7.1 | -7.3 |
| 6.2 | -0.7 | -0.4 | -3.4 | -3.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 0 | 4 | 4 | 4 |
| 0 | 4 | 7 | 8 |
Current Liabilities Current LiabilitiesCr | 4 | 2 | 2 | 5 |
Non Current Liabilities Non Current LiabilitiesCr | 4 | 0 | 1 | 5 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 4 | 6 | 9 | 5 |
Non Current Assets Non Current AssetsCr | 4 | 4 | 6 | 17 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | -1 | 0 | 2 |
Investing Cash Flow Investing Cash FlowCr | -1 | -1 | -2 | -11 |
Financing Cash Flow Financing Cash FlowCr | 0 | 3 | 6 | 6 |
|
Free Cash Flow Free Cash FlowCr | 0 | -2 | -3 | -10 |
| 626.0 | 607.7 | 62.9 | -152.2 |
CFO To EBITDA CFO To EBITDA% | 83.7 | -223.0 | -37.2 | -395.5 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 46 | 51 | 32 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 0.0 | 2.2 | 2.3 | 1.6 |
Price To Book Price To Book | 0.0 | 5.8 | 4.4 | 2.7 |
| 4.5 | 89.8 | 160.5 | -70.4 |
Profitability Ratios Profitability Ratios |
| 34.9 | 29.6 | 29.3 | 24.2 |
| 7.7 | 2.5 | 1.4 | -2.7 |
| 1.0 | -0.9 | -0.8 | -7.1 |
| 11.2 | -0.6 | -0.7 | -6.7 |
| 36.3 | -2.4 | -1.6 | -11.9 |
| 1.9 | -1.9 | -1.2 | -6.6 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Tapi Fruit Processing Limited is an Indian **FMCG** company specializing in the manufacturing and distribution of fruit and vegetable-based products. Established in **1999**, the company has evolved from a home-scale **papaya-based Tooty Fruity** operation into an **ISO 22000:2018** certified industrial entity. The company manages the entire value chain—from raw ingredient procurement to manufacturing and global distribution—with a strategic focus on high-margin segments including **Nutraceuticals** and **plant-based** snacks.
---
### **Core Manufacturing Infrastructure & Sustainability**
The company’s operations are centralized at its primary manufacturing facility in **Pipodara, Surat, Gujarat**. A pioneer in green manufacturing, Tapi Fruit was India’s first fruit processing industry to adopt commercial **renewable solar energy** in **2007**.
* **Energy Efficiency:** The facility currently utilizes an **87 Kw Roof Top Solar PV system**, which generated **82,345 units** in the most recent fiscal year.
* **Technology Integration:** To improve yield and reduce manual intervention, the company integrated **Automatic Pillow Packing** and **Double Twist Packing** machines (imported in **2023-24**).
* **Operational Scale-up:** As of **January 2025**, the company resumed full-scale production of jelly candies and gummies following a significant machinery overhaul designed for higher efficiency.
* **Workforce:** The company employs **47 full-time employees** (as of March 31, 2025) and has implemented an **ESOP - 2023** scheme, granting **34,250 options** to align staff interests with long-term growth.
---
### **Diversified Product Portfolio & Market Reach**
Tapi Fruit utilizes fruit and vegetable pulp to manufacture a wide range of **SKUs** across traditional confectionery and modern wellness categories.
| Category | Key Products |
| :--- | :--- |
| **Confectionery** | **Jelly Candies**, **Gummies**, **Jelly Twist**, **Jelly Bite**, **Fruit Berries**, **Ice Lolly** |
| **Fruit Products** | **Tooty Fruity** (Candied Papaya), **Candied Fruits**, **Fruit Papad**, **Fruit Katli** |
| **Preserves & Bases** | **Jams** (including Probiotic variants), **Fruit Crushes**, **Fruit Bars**, **Marmalades** |
| **Wellness (Subsidiary)** | **Nutraceutical Gummies** (Marketed under **TM Mediball** via Tapi Wellness Pvt Ltd) |
**Distribution Channels:**
* **Domestic & Export:** Operates a **PAN-India** network and exports to over **20 countries**, including the **USA, Canada, Australia, UAE, and New Zealand**.
* **Direct-to-Consumer (D2C):** Launched a dedicated **Online Shoppe Site & App** in **2023** and opened its first **Company Operated Retail Outlet** in **Surat** (July 2024).
* **Private Labeling:** Provides manufacturing services for third-party brands, including a **₹5.00 Crore** agreement with **Maalana Foods Private Limited** for FY 2026-27.
---
### **Strategic Pivot: Nutraceuticals & Pharmaceuticals**
In **March 2026**, the Board approved a significant alteration to the **Memorandum of Association (MoA)**, signaling a shift from traditional processing to high-margin wellness and medicinal products.
* **New Business Verticals:** The company is now authorized to manufacture and distribute **Vitamins, Probiotics, Prebiotics, Amino Acids**, and **Ayurvedic preparations**.
* **Ancillary Services:** Expansion into vialling, bottling, and the processing of tablets, capsules, and syrups.
* **Infrastructure Readiness:** Ongoing upgrades are targeting **GMP (Good Manufacturing Practice)** and **AYUSH** certifications to support these pharmaceutical-grade operations.
---
### **Subsidiary Performance: Tapi Wellness Private Limited**
The company’s expansion into the healthcare sector is primarily driven through its subsidiary, which focuses on dietary supplements and specialized formulations.
**Financial Performance (FY 2024-25):**
* **Turnover:** **2,69,101.63** (INR in Hundreds)
* **Net Profit (PAT):** **14,074.04** (INR in Hundreds)
* **Related Party Transaction Limit (FY 26-27):** **₹25.00 Crores**
---
### **Financial Performance & Capital Structure**
FY 2024-25 was a transitional year marked by a revenue decline due to planned production halts for facility upgrades.
**Standalone Financial Summary (INR in Hundreds):**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **17,49,760.90** | **21,01,666.52** | **~20,51,000.00** |
| **Growth (Y-o-Y)** | **(16.74%)** | **2.47%** | — |
| **Net Loss** | **(1,57,227.64)** | **(25,193.29)** | **(19,426.84)** |
**Capital & Debt Profile:**
* **Paid-up Capital:** **INR 4,27,300.00 Hundred** (4,273,000 equity shares).
* **Warrant Conversion:** Completed conversion of **103,500 warrants** at **INR 154.00** per share in FY25; no warrants remain outstanding.
* **New Investment:** **₹4.62 Crore** earmarked for capacity expansion.
* **Debt Financing:** Secured a **₹3.46 Crore** Term Loan and enhanced Cash Credit facilities to **₹3 Crore** via Indian Bank (Interest: **Repo + 2.70% p.a.**).
---
### **Growth Roadmap & 2030 Targets**
The company has outlined a clear trajectory for scaling operations and market presence:
* **Volume Target:** Mission to process **1 million metric tonnes** of fruit and vegetables by **2030**.
* **Employment Target:** Aiming to generate employment for **1,000 people** by **2030**.
* **Phase I Expansion:** Completed in **June 2025**, focusing on Fruit Leathers and existing line capacities.
* **R&D Focus:** Increasing investment in **shelf-life enhancement** and **nutrition** to capture the rising demand for organic and plant-based foods in urban and international markets.
---
### **Risk Management & Governance**
Tapi Fruit employs a structured risk mapping and trend analysis framework to mitigate operational and financial threats.
* **Input Volatility:** The company faces exposure to **inflationary pressures** in raw materials and **currency rate fluctuations** affecting exports.
* **Regulatory Environment:** Navigating a **high tax structure** within the Indian processed food industry.
* **Governance Oversight:** Internal controls are reviewed by an **Independent Internal Auditor** and overseen by the **Audit Committee**.
* **Promoter Stability:** The company is led by **Mr. Ghanshyam Lukhi** (Managing Director, **38.89%** holding) and **Mr. Ashokkumar Lukhi** (Whole-time Director, **26.37%** holding), ensuring strong leadership continuity.